| Similar Articles |
|---|
 |
The Motley Fool
January 10, 2005
W.D. Crotty |
This "dj" is Primed to Play Hits Medical device company dj Orthopedics reaps huge gains after a good sales report.   |
The Motley Fool
December 21, 2005
Stephen D. Simpson |
Biomet Takes a Bum Knee Company excuses aside, a subpar quarter lends credence to the notion that orthopedics companies are still in a tough spot. Investors, take note. |
The Motley Fool
April 26, 2005
Stephen D. Simpson |
Growth Is Knee-High Zimmer turns in another fine quarter, with strength in knee implants leading the way. |
The Motley Fool
October 5, 2005
Stephen D. Simpson |
Wright Goes Wrong A weak third quarter compounds troubles for this pipeline-challenged orthopedics player. There is no compelling reason to purchase this stock today. |
The Motley Fool
April 13, 2006
Stephen D. Simpson |
A Foolish Baby Shower: Stryker Here is a stock you can be comfortable with buying for your little one with the intention that it would be held for at least 18 years. |
The Motley Fool
July 27, 2006
Stephen D. Simpson |
Zimmer Provides Quarterly Information, and More In addition to its quarterly review, the orthopedic company gave some insight into the government probe. Investors, take note. |
The Motley Fool
January 27, 2006
Stephen D. Simpson |
Lightning Stryker The dust hasn't yet settled on the orthopedic sector, so wise investors should tread lightly with this medical technology company. |
The Motley Fool
March 21, 2006
Stephen D. Simpson |
Biomet's Stiff Joints Pricing isn't collapsing, but the orthopedics company isn't exactly prospering, either. Investors, beware. |
The Motley Fool
March 22, 2005
Stephen D. Simpson |
Can Biomet Elbow the Competition? The No. 4 player in orthopedics looks to close the gap. No matter what valuation metric you want to look at, Biomet shares look expensive on an absolute basis. |
The Motley Fool
July 27, 2006
Stephen D. Simpson |
Smith & Nephew: Better Is Good Enough For British medical device company Smith & Nephew investors, better-than-expected is just fine. |
The Motley Fool
October 27, 2005
Stephen D. Simpson |
Will Smith & Nephew Keep Flexing? This smaller, British, orthopedic company has competitive products, but industry trends could hurt it. However, the entire orthopedic sector is getting pretty interesting from a value perspective. |
The Motley Fool
October 18, 2006
Matthew Crews |
Stryker Is Steady Eddy How long can Stryker maintain its Steady Eddy persona? Net earnings will decelerate when gross margins peak. |
The Motley Fool
March 28, 2006
Stephen D. Simpson |
A Surprising Turn at Biomet The large orthopedic company replaces one of its founders. This change doesn't really make the stock dramatically more, or less, attractive than before. Investors, take note. |
The Motley Fool
March 20, 2006
Rich Smith |
Foolish Forecast: Biomet Flexes The bone specialist is due to release its fiscal third-quarter 2006 report tomorrow morning. Here's what investors need to know to make sense of it. |
The Motley Fool
September 14, 2005
Stephen D. Simpson |
Orthopedic Sector Stumbles Already antsy about potential pricing, investors reacted badly to British orthopedic company Smith & Nephew's earnings guidance. |
The Motley Fool
April 28, 2004
Glen Trematore |
Zimmer Makes a Family Proud Zimmer Holdings looks strong when compared with other orthopedic/medical device makers. |
BusinessWeek
October 3, 2005
Gene G. Marcial |
Giant Strides At Symmetry Symmetry Medical is sitting pretty in the fast-growing orthopedics market. |
The Motley Fool
August 3, 2006
Stephen D. Simpson |
Asymmetrical Medical It may pay for investors to be patient with this med-tech company while the industry is in a rough patch. |
The Motley Fool
July 28, 2005
Stephen D. Simpson |
Zimmer at a Simmer Strong demand for reconstructive products keeps this orthopedics company limber. Zimmer's 30-plus trailing price-to-earnings ratio still looks high, but it is in line with this industry's current multiples. |
The Motley Fool
August 28, 2008
Brian Orelli |
Stryker Strikes Back The orthopedics maker sues to stop a costly federal investigation. |
The Motley Fool
June 30, 2005
Stephen D. Simpson |
Biomet Wants Your Body Steady growth continues at the #4 orthopedics player. But Biomet shares haven't had a great year so far, hovering close to their 52-week low. |
The Motley Fool
July 20, 2007
Ryan Fuhrmann |
Stryker Does a Body Good The orthopedics company continues its double-digit growth in an industry with a bright future. Investors, take note. |
The Motley Fool
July 23, 2010
Jordan DiPietro |
Better Health Care Buy: Stryker or Zimmer Holdings? Which stock is a better purchase to consider? |
